S R Durham

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper

P Demoly, P. Demoly, S. Durham, 2017, Allergy.

Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

A J Wardlaw, S. Durham, A. Wardlaw, 1991, The Journal of clinical investigation.

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids

S. Durham, K. Chung, P. Barnes, 1998, Thorax.

Consensus statement * on the treatment of allergic rhinitis

J Bousquet, W J Fokkens, P. Howarth, 2000, Allergy.

Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma.

P Maestrelli, S. Durham, L. Fabbri, 1992, The Journal of allergy and clinical immunology.

Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid.

S. Durham, Q. Hamid, M. Jacobson, 1997, European journal of immunology.

Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness.

S. Durham, G. Menz, A. Kay, 1992, The American review of respiratory disease.